Cargando…
What to do in an oncology department to face the new COVID-19 era challenges?
Italy was the first European country to be hit by COVID-19 pandemic. As a consequence, Italian oncologists had to guarantee essential treatments although minimizing exposure to the virus, and accidental infection, of patients and healthcare professionals. As Department of Medical Oncology of the Uni...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387254/ https://www.ncbi.nlm.nih.gov/pubmed/32728951 http://dx.doi.org/10.1007/s12032-020-01400-x |
_version_ | 1783564083653509120 |
---|---|
author | Garattini, S. K. Bin, A. Donato, R. Mansutti, M. Rizzato, S. Troiero, G. Candoni, A. Fanin, R. Fasola, G. |
author_facet | Garattini, S. K. Bin, A. Donato, R. Mansutti, M. Rizzato, S. Troiero, G. Candoni, A. Fanin, R. Fasola, G. |
author_sort | Garattini, S. K. |
collection | PubMed |
description | Italy was the first European country to be hit by COVID-19 pandemic. As a consequence, Italian oncologists had to guarantee essential treatments although minimizing exposure to the virus, and accidental infection, of patients and healthcare professionals. As Department of Medical Oncology of the University Hospital of Udine, in this short report, we describe the measures that we have taken, and gradually updated, since February 26, 2020. All accesses to our Oncology facilities are currently regulated by entrance check-points where patients are screened for infections following dedicated algorithms. Up to date, after 6 weeks of systematic execution of swabs no physician, nurse or other individual of the staff has been found positive to COVID-19. Only one patient admitted for therapy has been identified as COVID-19 positive. The aim of our work is to propose a model, made up of a set of operative procedures, that may be adopted by all the oncologists that daily struggle to guarantee safety and care in Oncology during this COVID-19 emergency. |
format | Online Article Text |
id | pubmed-7387254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-73872542020-07-29 What to do in an oncology department to face the new COVID-19 era challenges? Garattini, S. K. Bin, A. Donato, R. Mansutti, M. Rizzato, S. Troiero, G. Candoni, A. Fanin, R. Fasola, G. Med Oncol Short Communication Italy was the first European country to be hit by COVID-19 pandemic. As a consequence, Italian oncologists had to guarantee essential treatments although minimizing exposure to the virus, and accidental infection, of patients and healthcare professionals. As Department of Medical Oncology of the University Hospital of Udine, in this short report, we describe the measures that we have taken, and gradually updated, since February 26, 2020. All accesses to our Oncology facilities are currently regulated by entrance check-points where patients are screened for infections following dedicated algorithms. Up to date, after 6 weeks of systematic execution of swabs no physician, nurse or other individual of the staff has been found positive to COVID-19. Only one patient admitted for therapy has been identified as COVID-19 positive. The aim of our work is to propose a model, made up of a set of operative procedures, that may be adopted by all the oncologists that daily struggle to guarantee safety and care in Oncology during this COVID-19 emergency. Springer US 2020-07-29 2020 /pmc/articles/PMC7387254/ /pubmed/32728951 http://dx.doi.org/10.1007/s12032-020-01400-x Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Short Communication Garattini, S. K. Bin, A. Donato, R. Mansutti, M. Rizzato, S. Troiero, G. Candoni, A. Fanin, R. Fasola, G. What to do in an oncology department to face the new COVID-19 era challenges? |
title | What to do in an oncology department to face the new COVID-19 era challenges? |
title_full | What to do in an oncology department to face the new COVID-19 era challenges? |
title_fullStr | What to do in an oncology department to face the new COVID-19 era challenges? |
title_full_unstemmed | What to do in an oncology department to face the new COVID-19 era challenges? |
title_short | What to do in an oncology department to face the new COVID-19 era challenges? |
title_sort | what to do in an oncology department to face the new covid-19 era challenges? |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387254/ https://www.ncbi.nlm.nih.gov/pubmed/32728951 http://dx.doi.org/10.1007/s12032-020-01400-x |
work_keys_str_mv | AT garattinisk whattodoinanoncologydepartmenttofacethenewcovid19erachallenges AT bina whattodoinanoncologydepartmenttofacethenewcovid19erachallenges AT donator whattodoinanoncologydepartmenttofacethenewcovid19erachallenges AT mansuttim whattodoinanoncologydepartmenttofacethenewcovid19erachallenges AT rizzatos whattodoinanoncologydepartmenttofacethenewcovid19erachallenges AT troierog whattodoinanoncologydepartmenttofacethenewcovid19erachallenges AT candonia whattodoinanoncologydepartmenttofacethenewcovid19erachallenges AT faninr whattodoinanoncologydepartmenttofacethenewcovid19erachallenges AT fasolag whattodoinanoncologydepartmenttofacethenewcovid19erachallenges |